Hrt Financial LP Vbi Vaccines Inc Transaction History

Hrt Financial LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.38 - $22.5 $49,153 - $2.91 Million	129,352 Added 158.16%	211,136 $82,000
Q3 2022 Nov 14, 2022	SELL	$0.73 - $23.4 $165,085 - $5.29 Million	-226,144 Reduced 73.44%	81,784 $57,000
Q2 2022 Aug 12, 2022	BUY	$0.66 - $1.81 $203,232 - $557,349	307,928 New	307,928 $248,000
Q1 2022 May 16, 2022	SELL	$1.27 - $2.47 $103,983 - $202,236	-81,877 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.21 - $3.22 $730,864 - $1.06 Million	-330,708 Reduced 80.16%	81,877 $191,000
Q3 2021 Nov 15, 2021	SELL	$2.8 - $3.72 $268,646 - $356,915	-95,945 Reduced 18.87%	412,585 $1.28 Million
Q2 2021 Aug 16, 2021	BUY	$2.61 - $4.17 $1.06 Million - $1.7 Million	406,688 Added 399.33%	508,530 $1.7 Million
Q1 2021 May 17, 2021	BUY	$2.91 - $4.32 $296,360 - $439,957	101,842 New	101,842 $316,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.